US Home - Resources and whitepapers - Whitepapers - Ready-To-Use products now, the future: safety and advantages

Ready-To-Use products now, the future: safety and advantages


Mary Nazzal, Pharm.D., Clinical IQ, LLC., Eric S. Kastango, MBA, RPh, FASHP, Principal-CEO, Clinical IQ, LLC & CriticalPoint, LLC


The Institute for Safe Medication Practices (ISMP) Guidelines for Safe Preparation of Compounded Sterile Preparations that was first published in 2013 recommends “To the maximum extent possible, Commercially-Prepared, premixed parenteral products and unit dose syringes are used versus manually compounded sterile products.”1 There are a lot of options available for premix/ready-to-administer/ready-to-use products.

Hopefully, your facility is taking advantage of these product benefits and manufacturers can overcome some of the challenges so that we may see an increase in affordable commercially prepared premixes and other types of ready-to-use products.

You can download the whitepaper by clicking the link below.

Download this whitepaper (PDF)